Studies in animal and human models with different methodological designs have described that chronic opioid use can lead to dysregulated immune response, increased intestinal barrier permeability, bacterial translocation, increased risk of intestinal sepsis, as well as symptoms of abdominal distension [114]
20.4% CagriSema Trial REDEFINE 2 (NEJM 2025) Duration 68 weeks Population T2D + BMI 27 (n=1,206) Mean Weight Loss 13.7% CagriSema vs 3.4% placebo
A.EksiA
Oxidative stress destroys collagen, leading to sagging, fine lines, and dullness
Benefits for thymulin therapy include: combatting infections (viral or bacterial), boosting immune cell activity, improving tissue repair and healing, and reducing inflammation
Patients who are pregnant or breastfeeding, patients with active malignancy, patients with certain vascular conditions where angiogenesis is a concern, and patients on specific anticoagulants may not be candidates